STTCOMP RCE FA LONG
RECCE Pharmaceutical
MC ~ $213m
SP ~ 1.25c
Consolidated in a band between 90c and $1.30, with $1.30 my break point for a run to $1.70.
Fundamental news also helping interest and technical chart. Healthcare sector my favourite area for investment at present.
Recce Pharmaceuticals Ltd (RCE) is a drug discovery and development business commercialising a new class of synthetic antibiotics with broad spectrum activity designed to address the global health challenge of antibiotic resistant superbugs. Its patented lead candidate known as RECCE 327 has been developed for the treatment of blood infections and sepsis derived from E. coli and S. aureus bacteria - including their superbug forms.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 12 Apr
Short Term Trading Week Starting: 12 Apr, page-102
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online